Clinical trial · Observational
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphoid Cell Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (questionnaire)
- description
- Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.
- interventionNames
- Other: Questionnaire Administration
Primary outcomes (1)
- measure
- To establish a standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivor-ship.
- timeFrame
- through study completion, an average of a year.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Age 21 and above * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology * Maintenance of an active practice that includes prostate cancer patients * English speaking Exclusion Criteria: * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer * Prisoners, children, and adults unable to consent to participation will also be excluded * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status
References
Publications (0)
Data not yet available